Healthcare (SH:603313)2019-04-29 16:00Financial Performance - Operating revenue increased by 28.78% to CNY 611,220,106.02 year-on-year[12] - Net profit attributable to shareholders increased by 1,547.30% to CNY 4,574,340.20 compared to the same period last year[12] - Basic and diluted earnings per share were both CNY 0.02, an increase of 1,450% year-on-year[12] - The company's revenue for the reporting period reached ¥787,122,185.19, representing a 28.78% increase compared to ¥611,220,106.02 in the same period last year, primarily due to increased sales volume[22] - Net profit attributable to shareholders for Q1 2019 was CNY 596,761,028.16, up from CNY 525,362,023.27 in Q1 2018, indicating a growth of approximately 13.6%[41] - The company's total profit for Q1 2019 was CNY 102,824,714.53, compared to CNY 12,586,533.59 in Q1 2018, marking an increase of 717.5%[45] - The total comprehensive income for Q1 2019 was CNY 75,694,480.89, compared to CNY 4,483,690.20 in Q1 2018, showing a growth of 1,588.5%[47] Cash Flow - Net cash flow from operating activities improved by 1,351.54% to CNY -9,640,744.83 year-on-year[12] - The net cash flow from operating activities was ¥120,658,185.58, a significant increase of 1351.54% compared to a negative cash flow of ¥9,640,744.83 in the previous year, mainly due to increased product sales collections[25] - The net cash flow from operating activities was CNY 120,658,185.58 in Q1 2019, a turnaround from a negative cash flow of CNY -9,640,744.83 in Q1 2018[54] - Cash inflow from operating activities totaled CNY 970,320,501.66 in Q1 2019, up from CNY 748,916,203.68 in Q1 2018, reflecting a growth of about 29.5%[54] Assets and Liabilities - Total assets decreased by 0.28% to CNY 3,375,853,349.34 compared to the end of the previous year[12] - The total assets of the company amounted to ¥3,366,477,468.25, slightly down from ¥3,375,853,349.34 at the beginning of the period[26] - The total liabilities decreased to ¥1,401,284,898.57 from ¥1,490,721,735.56, indicating a reduction in overall debt levels[33] - Total liabilities as of March 31, 2019, were CNY 1,234,319,171.28, a decrease from CNY 1,329,990,430.17 at the end of 2018[41] - The company reported accounts receivable of approximately $567.03 million, remaining stable compared to the previous period[61] Shareholder Information - The total number of shareholders at the end of the reporting period was 15,386[16] - The largest shareholder, Ni Zhanggen, holds 63.78% of the shares, with 154,154,861 shares pledged[16] - The total equity attributable to shareholders of the parent company was CNY 1,854,503,842.49, indicating a stable equity position[68] Expenses - The company reported a significant increase in management expenses by 33.22% to ¥45,421,616.43 from ¥34,096,438.10, primarily due to increased compensation for management personnel[22] - Total operating costs for Q1 2019 were CNY 715,081,334.86, compared to CNY 605,020,207.26 in Q1 2018, reflecting an increase of about 18.2%[41] - The financial expenses for Q1 2019 were CNY 39,121,142.67, an increase of 67.6% from CNY 23,308,330.90 in Q1 2018[45] Other Financial Metrics - Non-operating income totaled CNY 26,424,815.22, with significant contributions from government subsidies and other non-recurring gains[14] - The fair value change income reached ¥30,534,999.74, a 385.18% increase from ¥6,293,483.87, attributed to the increase in the fair value of forward foreign exchange contracts due to exchange rate changes[22] - The company reported a fair value change gain of CNY 30,534,999.74 in Q1 2019, up from CNY 6,293,483.87 in Q1 2018, representing an increase of 385.5%[45] Compliance and Standards - The company executed new financial accounting standards starting January 1, 2019, impacting the financial reporting of comparable periods[68] - The company’s financial report reflects compliance with the revised accounting standards issued by the Ministry of Finance in 2017[68]